Resources from the same session
507O - Impact of lean body mass-based oxaliplatin dosage on neurotoxicity in adjuvant treatment of stage III colorectal cancer: Final results of the phase II randomized multicenter LEANOX trial
Presenter: Eric Assenat
Session: Proffered paper session 1: GI tumours, lower
Resources:
Abstract
Slides
Webcast
512O - Adjuvant aspirin treatment in PIK3CA mutated colon cancer patients: The phase III, prospective-randomized placebo-controlled multicenter SAKK 41/13 trial
Presenter: Ulrich Güller
Session: Proffered paper session 1: GI tumours, lower
Resources:
Abstract
Slides
Webcast
Invited Discussant 507O and 512O
Presenter: Sebastian Stintzing
Session: Proffered paper session 1: GI tumours, lower
Resources:
Slides
Webcast
LBA24 - Neoadjuvant immunotherapy in locally advanced MMR-deficient colon cancer: 3-year disease-free survival from NICHE-2
Presenter: Myriam Chalabi
Session: Proffered paper session 1: GI tumours, lower
Resources:
Abstract
Slides
Webcast
503O - Neoadjuvant nivolumab (nivo) plus relatlimab (rela) in MMR-deficient colon cancer: Results of the NICHE-3 study
Presenter: Peter de Gooyer
Session: Proffered paper session 1: GI tumours, lower
Resources:
Abstract
Slides
Webcast
504O - IMHOTEP Phase II trial of neoadjuvant pembrolizumab in dMMR/MSI tumors: Results of the colorectal cancer cohort
Presenter: Christelle de la Fouchardiere
Session: Proffered paper session 1: GI tumours, lower
Resources:
Abstract
Slides
Webcast
Invited Discussant LBA24, 503O and 504O
Presenter: Jenny Seligmann
Session: Proffered paper session 1: GI tumours, lower
Resources:
Slides
Webcast
Q&A
Session: Proffered paper session 1: GI tumours, lower
Resources:
Webcast